VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
WST
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
WSTWest Pharmaceutical Services, Inc.
$375.97$26.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksWSTQuarterly Financials

West Pharmaceutical Services, Inc. (WST) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

West Pharmaceutical Services, Inc. (WST) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

WST Income Statement

Quarterly statement

WST Income Statement

West Pharmaceutical Services, Inc. (WST) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue872.3M844.9M805M804.3M766.2M698.2M748.5M746.9M702M695.3M732.1M747.5M754.2M715.9M708.4M686.4M771.6M719.7M729M706.6M
Revenue Growth %13.85%21.01%7.55%7.69%9.15%0.42%2.24%-0.08%-6.92%-2.88%3.35%8.9%-2.26%-0.53%-2.83%-2.86%6.56%7.26%25.62%28.87%
Cost of Goods Sold543.1M548.5M501.1M510.8M493M465.5M474.1M481.7M470.7M464M453.1M458M462M445.3M445M418.9M451.8M434.9M436.4M418.1M
COGS % of Revenue62.26%64.92%62.25%63.51%64.34%66.67%63.34%64.49%67.05%66.73%61.89%61.27%61.26%62.2%62.82%61.03%58.55%60.43%59.86%59.17%
Gross Profit329.2M296.4M303.9M293.5M273.2M232.7M274.4M265.2M231.3M231.3M279M289.5M292.2M270.6M263.4M267.5M319.8M284.8M292.6M288.5M
Gross Margin %37.74%35.08%37.75%36.49%35.66%33.33%36.66%35.51%32.95%33.27%38.11%38.73%38.74%37.8%37.18%38.97%41.45%39.57%40.14%40.83%
Gross Profit Growth %20.5%27.37%10.75%10.67%18.12%0.61%-1.65%-8.39%-20.84%-14.52%5.92%8.22%-8.63%-4.99%-9.98%-7.28%1.07%4.44%38.35%51.13%
Operating Expenses150.1M119.3M146.8M119.8M115M104.3M103.8M97.4M100.5M104.3M108.4M98.4M104.9M103.1M101.6M79.9M95.9M98M111.7M105M
OpEx % of Revenue17.21%14.12%18.24%14.89%15.01%14.94%13.87%13.04%14.32%15%14.81%13.16%13.91%14.4%14.34%11.64%12.43%13.62%15.32%14.86%
Selling, General & Admin117.6M99.5M106.5M102.7M95.9M88M85.3M81.9M83M86.7M90M89M88.4M86M85.7M66.3M81.5M83.4M98M91.9M
SG&A % of Revenue13.48%11.78%13.23%12.77%12.52%12.6%11.4%10.97%11.82%12.47%12.29%11.91%11.72%12.01%12.1%9.66%10.56%11.59%13.44%13.01%
Research & Development19.7M15.8M21.8M17.1M19.1M16.3M18.5M15.5M17.5M17.6M18.4M16.4M16.5M17.1M15.9M13.6M14.4M14.6M13.7M13.1M
R&D % of Revenue2.26%1.87%2.71%2.13%2.49%2.33%2.47%2.08%2.49%2.53%2.51%2.19%2.19%2.39%2.24%1.98%1.87%2.03%1.88%1.85%
Other Operating Expenses1000K1000K1000K00000000-1000K00000000
Operating Income179.1M177.1M156.6M173.7M158.2M128.4M170.6M167.8M130.8M127M170.6M191.1M187.3M167.5M161.8M187.6M223.9M186.8M180.9M183.5M
Operating Margin %20.53%20.96%19.45%21.6%20.65%18.39%22.79%22.47%18.63%18.27%23.3%25.57%24.83%23.4%22.84%27.33%29.02%25.96%24.81%25.97%
Operating Income Growth %13.21%37.93%-8.21%3.52%20.95%1.1%0%-12.19%-30.17%-24.18%5.44%1.87%-16.35%-10.33%-10.56%2.23%6.67%3.61%47.91%71.98%
EBITDA179.1M221.7M203.6M216.7M199.6M168.4M211.3M208M169.7M162.6M206.5M226.8M221.4M199.1M192.9M217.4M254M216.4M215.3M213.5M
EBITDA Margin %20.53%26.24%25.29%26.94%26.05%24.12%28.23%27.85%24.17%23.39%28.21%30.34%29.36%27.81%27.23%31.67%32.92%30.07%29.53%30.22%
EBITDA Growth %-10.27%31.65%-3.64%4.18%17.62%3.57%2.32%-8.29%-23.35%-18.33%7.05%4.32%-12.83%-7.99%-10.4%1.83%6.41%3.34%42.77%53.27%
D&A (Non-Cash Add-back)044.6M47M43M41.4M40M40.7M40.2M38.9M35.6M35.9M35.7M34.1M31.6M31.1M29.8M30.1M29.6M34.4M30M
EBIT179.1M173.9M162.5M174.1M157.1M110.9M164.9M165.2M130.2M128.9M169.3M189.9M187.5M160.1M130.3M138.3M229M189.5M185M182.8M
Net Interest Income1.2M3.2M5.3M4.6M3.5M3.7M4.8M3.9M2.5M4.7M8.3M5.9M2.4M2.6M1.3M-600K-1.4M-1.8M-2.8M-1.3M
Interest Income1.2M3.2M5.3M4.7M3.6M4.1M4.8M4.6M4M6.2M9.4M8.8M5M4.8M2.9M1.5M400K300K300K400K
Interest Expense000100K100K400K0700K1.5M1.5M1.1M2.9M2.6M2.2M1.6M2.1M1.8M2.1M3.1M1.7M
Other Income/Expense1M3M8.8M300K3.8M-14.5M-3.7M600K2.4M4.7M900K-400K2.6M-3.9M-29.9M-46.6M8.8M8.2M1M4.1M
Pretax Income180.1M180.1M165.4M174M162M113.9M166.9M168.4M133.2M131.7M171.5M190.7M189.9M163.6M131.9M141M232.7M195M181.9M187.6M
Pretax Margin %20.65%21.32%20.55%21.63%21.14%16.31%22.3%22.55%18.97%18.94%23.43%25.51%25.18%22.85%18.62%20.54%30.16%27.09%24.95%26.55%
Income Tax32.2M44.7M33.3M34M30.2M24.1M36.8M32.4M21.9M16.4M34.5M29.4M34.8M23.6M28.9M20.4M44.2M21.2M34.2M12M
Effective Tax Rate %17.88%24.82%20.13%19.54%18.64%21.16%22.05%19.24%16.44%12.45%20.12%15.42%18.33%14.43%21.91%14.47%18.99%10.87%18.8%6.4%
Net Income154M138.8M132.1M140M131.8M89.8M130.1M136M111.3M115.3M137M161.3M155.1M140M103M120.6M188.5M173.8M147.7M175.6M
Net Margin %17.65%16.43%16.41%17.41%17.2%12.86%17.38%18.21%15.85%16.58%18.71%21.58%20.56%19.56%14.54%17.57%24.43%24.15%20.26%24.85%
Net Income Growth %16.84%54.57%1.54%2.94%18.42%-22.12%-5.04%-15.69%-28.24%-17.64%33.01%33.75%-17.72%-19.45%-30.26%-31.32%0.64%14.95%50.1%113.37%
Net Income (Continuing)147.9M135.4M132.1M140M131.8M89.8M130.1M136M111.3M115.3M137M161.3M155.1M140M103M120.6M188.5M173.8M147.7M175.6M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)2.151.921.821.931.821.231.781.851.511.551.832.142.061.851.361.592.492.291.932.31
EPS Growth %18.13%56.1%2.25%4.32%20.53%-20.65%-2.73%-13.55%-26.7%-16.22%34.56%34.59%-17.27%-19.21%-29.53%-31.17%0.81%15.08%49.61%111.93%
EPS (Basic)2.171.931.831.941.821.241.791.871.521.571.852.172.091.881.381.622.532.341.982.37
Diluted Shares Outstanding71.3M72.4M72.7M72.7M72.8M73M73.7M73.4M73.7M74.3M75M75.3M75.4M75.7M75.6M75.7M75.8M76M76.4M76M
Basic Shares Outstanding70.8M72M72.3M72.3M72.3M72.5M73M72.8M73M73.5M74.1M74.3M74.3M74.5M74.4M74.4M74.4M74.4M74.5M74.1M
Dividend Payout Ratio10.19%11.38%11.96%10.79%11.46%16.93%11.76%10.66%13.12%12.75%10.8%8.68%9.09%10.07%13.69%11.19%6.95%7.71%9%7.18%